(Q44692125)

5 December 2017

Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys (English)

1 reference

5 December 2017

1 reference

1 reference

Nancy Bélanger

1

1 reference

5 December 2017

Laurent Grégoire

series ordinal

2

1 reference

5 December 2017

Abdallah Hadj Tahar

series ordinal

3

1 reference

5 December 2017

Paul J Bédard

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

18

1 reference

5 December 2017

12

1 reference

5 December 2017

1436-1441

1 reference

Modification of Parkinsonism--chronic treatment with L-dopa

5 December 2017

1 reference

Treatment of Parkinsonism With Levodopa

21 January 2018

1 reference

Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders

21 January 2018

1 reference

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

21 January 2018

1 reference

Levodopa-induced dyskinesia: review, observations, and speculations

21 January 2018

1 reference

Dopamine autoreceptor function is lost in advanced Parkinson's disease.

21 January 2018

1 reference

Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance

21 January 2018

1 reference

Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?

21 January 2018

1 reference

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

21 January 2018

1 reference

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease.

21 January 2018

1 reference

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

21 January 2018

1 reference

Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated

21 January 2018

1 reference

Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices

21 January 2018

1 reference

Presynaptic dopaminergic modulation of cortical input to the striatum

21 January 2018

1 reference

Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.

21 January 2018

1 reference

Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys

21 January 2018

1 reference

In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine

21 January 2018

1 reference

Ca2+-channels involved in neostriatal glutamatergic transmission.

21 January 2018

1 reference

Involvement of N- and non-N-type calcium channels in synaptic transmission at corticostriatal synapses.

21 January 2018

1 reference

Dopaminergic modulation at the olfactory nerve synapse.

21 January 2018

1 reference

Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata

21 January 2018

1 reference

Spontaneous synaptic potentials in dopamine-denervated neostriatal neurons.

21 January 2018

1 reference

Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms

21 January 2018

1 reference

The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset

21 January 2018

1 reference

Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors.

21 January 2018

1 reference

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I

21 January 2018

1 reference

Short- and long-duration responses to levodopa during the first year of levodopa therapy.

21 January 2018

1 reference

Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs

21 January 2018

1 reference

Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico--striatal terminals in vitro

21 January 2018

1 reference

Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.

21 January 2018

1 reference

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

21 January 2018

1 reference

Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.10589

1 reference

release_pekntxdmqbemnbc6kqjgksnawe

5 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pekntxdmqbemnbc6kqjgksnawe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference